RAREUltragenyxHealth Care
$23.94EarningsAug 4, 2026
1D—1W—1M—3M—1Y—
Market cap$2.4BCompany infoRevenue$669.4M52-wk range$19 – $41IndustryBiotechnologyWebsiteultragenyx.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▼ −3.5% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E———
P / S3.6×3846
3
18
P / FCF———
EV / EBITDA———
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin83.6%9488
84%
96%
Operating margin-83.9%14
-179%
-80%
Net margin-91.0%24
-197%
-86%
ROE———
ROIC-46.0%15
-1477%
-27%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity———
Net debt / EBITDA———
Current ratio2.026952
Interest coverage-8.2×37
Per shareTTM, with year-over-year change
Revenue / share$6.65▲ +13%
EPS (diluted)$-6.11▼ −4%
FCF / share$-4.84▼ −18%
Est. EPS growth (fwd)—